Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.To provide sales support and distribution services for authorised generic versions of Allegra-D 12 hour extended-release tablets and Drisdol
Subscribe to our email newsletter
Prasco Laboratories has entered into agreements with Winthrop US, a business of sanofi-aventis US. As per the agreemnts, it is expected to provide sales support and distribution services to Winthrop US for authorised generic versions of Allegra-D 12 Hour (fexofenadine HCl 60mg and pseudoephedrine HCl 120mg) extended-release tablets and Drisdol (ergocalciferol) capsules in the US under the Winthrop label.
The company said that Fexofenadine HCl and pseudoephredrine HCl extended-release tablets and ergocalciferol capsules represent the first two products launched in the US by Winthrop US under the Winthrop label with Prasco providing sales support and distribution services to Winthrop US.
Thomas Arington, CEO of Prasco, said: “We are especially proud to expand our relationship with sanofi-aventis US, and we are certainly pleased to provide pharmacists and consumers with these authorised generic options. Consumers and pharmacists can have confidence in their prescription drug choices, when they have the identical product, quality, reliability of supply and the identical experience that only the brand can provide.”